Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

AstraZeneca’s COVID-19 Antibody Treatment Scores Approval In Europe

By Vandana Singh
September 20, 10:03 AM
The European Commission has approved AstraZeneca plc’s (NASDAQ:AZN) Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting antibody combination as COVID-19 treatment…

AZN

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Haleon Clocks Double Digit Growth In Interim Revenue, Profits; Sticks To Annual Guidance

By Vandana Singh
September 20, 9:49 AM
Haleon PLC (NYSE:HLN) reported a strong performance in 1H of 2022 in its first earnings report since separating from GSK plc (NYSE:GSK) in…

GSK

Read More
1 minute read
  • General
  • Health Care
  • News

Peloton Marks Entry Into ‘Rowing’ Category – What’s The New Workout?

By Shivani Kumaresan
September 20, 8:47 AM
Peloton Interactive Inc (NASDAQ:PTON) has unveiled Peloton Row, marking its entry into rowing. Rowing is known for being an efficient, low-impact…

PTON

Read More
5 minute read
  • Commodities
  • General
  • Health Care
  • Large Cap
  • Legal
  • M&A
  • Markets
  • Media
  • News
  • Tech
  • Top Stories

Top Financial Media Stories Tuesday, September 20: Apple Feels The Forex Pinch, Pepsi Ends Russian Production, Beyond Meat’s COO Arrested And More..

By Vandana Singh
September 20, 8:21 AM
Reuters What Recession? AmEx Shares Ambitious Hiring Plans As Peers Let Go Staff

AAPL

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

China-Based COVID-19 Shot Neutralizes Omicron Subvariants

By Vandana Singh
September 20, 7:29 AM
China-based Clover Biopharmaceuticals Ltd announced data from its ongoing Phase 3 study evaluating SCB-2019 (CpG 1018/Alum) as a universal COVID-19 booster…

DVAX

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Legal
  • M&A
  • Movers
  • News
  • Trading Ideas

Judge Says Yes To $13B UnitedHealth-Change Healthcare Merger: Report

By Vandana Singh
September 20, 7:18 AM
A U.S. judge on Monday denied the Justice Department's request to stop UnitedHealth Group Inc's (NYSE: UNH) $13 billion buyout deal for Change Healthcare Inc (NASDAQ: CHNG).

CHNG

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks
  • Price Target

Multiple Sclerosis Is A Crowded Space, But This Stock Is A Potential 6X Multi-bagger

By Vandana Singh
September 19, 3:03 PM
HC Wainwright assumes coverage on Immunic Inc (NASDAQ:IMUX), a late-stage clinical biotech company developing oral small molecule inhibitors for multiple sclerosis (MS)…

IMUX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Price Target
  • Small Cap

Analyst Builds Bullish Case For This Neuromuscular Company, Sees 200% Upside

By Vandana Singh
September 19, 2:39 PM
HC Wainwright has assumed coverage on Scholar Rock Holding Corp (NASDAQ:SRRK) with a Buy rating and price target of $30. The analyst writes…

SRRK

Read More
1 minute read
  • Biotech
  • Buybacks
  • General
  • Health Care
  • News
  • Small Cap

Theravance Outlines $250M Capital Return Program; To Repurchase GSK’s Entire Holdings

By Vandana Singh
September 19, 2:28 PM
Theravance Biopharma Inc (NASDAQ:TBPH) is buying back over 9.6 million shares from GSK plc (NYSE:GSK) for roughly $94 million, according to an…

GSK

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Price Target
  • Small Cap

HC Wainwright Sees 40% Upside For This Once Battered Stock With Pipeline Turnaround

By Vandana Singh
September 19, 2:02 PM
HC Wainwright is assuming coverage on AnaptysBio Inc (NASDAQ:ANAB) with a Buy Rating and a price target of $35 at a unique inflection…

ANAB

Posts pagination

Previous 1 … 408 409 410 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service